-
April 1, 2024 Lupin Receives Tentative Approval from U.S. FDA for Migalastat Capsules
-
March 28, 2024 Lupin Receives Approval from U.S. FDA for Eslicarbazepine Acetate Tablets
-
March 19, 2024 Lupin Receives Approval from U.S. FDA for Aripiprazole Tablets, USP
-
March 18, 2024 Lupin Appoints Christoph Funke as Chief Technical Operations Officer
-
March 15, 2024 Lupin Receives Approval from U.S. FDA for Doxycycline for Injection USP
-
March 11, 2024 Lupin and Birmingham City University Honour Graduates of Master’s Programme in Advancing Diabetes Care
-
March 8, 2024 Lupin Appoints Rakesh Bhardwaj as Chief Information Officer
-
February 23, 2024 Lupin Enters the S&P Global Sustainability Yearbook 2024
-
February 16, 2024 Lupin Receives Approval from U.S. FDA for Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate Tablets)